Related references
Note: Only part of the references are listed.Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
G.-B. Jang et al.
CANCER RESEARCH (2015)
Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
Namita Kundu et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
Mousumi Majumder et al.
CANCER SCIENCE (2014)
Wnt signaling in triple negative breast cancer is associated with metastasis
Nandini Dey et al.
BMC CANCER (2013)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L. Chaffer et al.
CELL (2013)
Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
Weiren Luo et al.
PLOS ONE (2013)
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Alysha K. Croker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model
Xiping Xin et al.
LABORATORY INVESTIGATION (2012)
Embryonic Morphogen Nodal Promotes Breast Cancer Growth and Progression
Daniela F. Quail et al.
PLOS ONE (2012)
Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors
Timothy A. Blauwkamp et al.
NATURE COMMUNICATIONS (2012)
Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
J. Chen et al.
BRITISH JOURNAL OF CANCER (2010)
Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer
Rabindra N. Bhattacharjee et al.
CANCER SCIENCE (2010)
Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome
Jae Il Kim et al.
MOLECULAR CANCER RESEARCH (2010)
Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression
Farhad Vesuna et al.
NEOPLASIA (2009)
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
Yutaka Matsuda et al.
BREAST CANCER RESEARCH (2009)
Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment
Xiaobing Yu et al.
CELL STEM CELL (2008)
Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity
David A. Hess et al.
STEM CELLS (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway
Robert J. George et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Cyclooxygenase-2-derived prostaglandin E-2 protects mouse embryonic stem cells from apoptosis
Jun-Yang Liou et al.
STEM CELLS (2007)
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
AV Timoshenko et al.
BRITISH JOURNAL OF CANCER (2006)
Cancer stem cells: An old idea - A paradigm shift
MS Wicha et al.
CANCER RESEARCH (2006)
Aberrant activation of Notch signaling in human breast cancer
S Stylianou et al.
CANCER RESEARCH (2006)
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
RE Harris et al.
BMC CANCER (2006)
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice
LR Howe et al.
CANCER RESEARCH (2005)
Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation
A Pozzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells
AV Timoshenko et al.
EXPERIMENTAL CELL RESEARCH (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases
H Fujino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
K Subbaramaiah et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis
JG Rozic et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Share Paper
